2m 2m 2m 2m 2m 2m 2m
Enlivex (ENLV)
NASDAQ
$2.11+$0.02 (+0.77%)
Price as of Aug 03, 2026 7:29 AM EDT- $496.1MMarket Cap
- -90.39%1-Year Change
- BiotechnologyIndustry
Enlivex (ENLV)
$2.11+$0.02 (+0.77%)
ENLV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.09 | ||
Change | +$0.14 (+7.18%) | ||
Open | $1.91 | ||
High | $2.16 | ||
Low | $1.80 | ||
Previous Close | $1.95 | ||
Volume | 341,462 | ||
30-Day Average Volume | 301,776 | ||
1-Week Change | -50.24% | ||
1-Month Change | -74.66% | ||
1-Year Change | -90.39% | ||
3-Year Change | -94.56% | ||
5-Year Change | -98.17% | ||
Fundamentals | |||
Shares Outstanding | 237.4M | ||
Total Assets | $2.3B | ||
Market Cap | $496.1M | ||
Enterprise Value | $494.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 07/09/2026 | ||
Earnings & Revenue